Ranbaxy’s API Business Reports Rise in Sales

Ranbaxy Laboratories (Gurgaon, India) says that its active pharmaceutical ingredients (API) business reported sales of $35 million in the third quarter of 2011, compared with sales of $23 million in the year-ago quarter. Profits for the API business were not disclosed. The company made 38 Drug Master Filings for APIs during the quarter, Ranbaxy says. Ranbaxy reported a total net loss of $103 million in the third quarter of 2011, compared with a net profit of $66 million in the year-ago quarter. The company’s total sales increased to $443 million in the...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers